ID: ALA14651

Max Phase: Preclinical

Molecular Formula: C10H12ClFN2O2

Molecular Weight: 210.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.Oc1cc(CC2=NCCN2)cc(F)c1O

Standard InChI:  InChI=1S/C10H11FN2O2.ClH/c11-7-3-6(4-8(14)10(7)15)5-9-12-1-2-13-9;/h3-4,14-15H,1-2,5H2,(H,12,13);1H

Standard InChI Key:  ITZCASHRRUACIR-UHFFFAOYSA-N

Associated Targets(Human)

Homo sapiens 32628 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin (5-HT) receptor 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 210.21Molecular Weight (Monoisotopic): 210.0805AlogP: 0.78#Rotatable Bonds: 2
Polar Surface Area: 64.85Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.31CX Basic pKa: 11.78CX LogP: 0.41CX LogD: -0.42
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.63Np Likeness Score: 0.13

References

1. Miller DD, Hamada A, Clark MT, Adejare A, Patil PN, Shams G, Romstedt KJ, Kim SU, Intrasuksri U, McKenzie JL..  (1990)  Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets.,  33  (4): [PMID:2157007] [10.1021/jm00166a009]

Source